Sabine Oertelt-Prigione has been appointed Professor of Gender in Primary and Transmural Care at Radboud University/the Radboud university medical center. She is a physician specialized in internal medicine and public health. She has been working on the implications of sex and gender in biomedical and public health research since 2009 at the Institute of Gender in Medicine at Charité, Universitätsmedizin, in Berlin. She developed the first systematic database on sex and gender-specific literature and co-edited one of the first textbooks on gender medicine.Sabine Oertelt-Prigione (1978), graduated from the Medical School, University of Milan, Italy in 2003 with honors After that, she was trained as a specialist in Internal Medicine. In 2012 she obtained her Master of Science (Public Health) at the University of London / London School of Hygiene and Tropical Medicine. In 2014, she obtained her PHD - magna cum laude - to Charité - Universitätsmedizin Berlin. One year later she obtained her Habilitation (second promotion / postgraduate teaching license) Internal Medicine. In 2014 she won the Max Rubner Prize for Innovations of the Charité Foundation, for the first project in the field of sexual harassment in German hospitals.
Prof. Oertelt-Prigione will be working at the Department of Primary and Community Care, where she will research gender sensitive patient-oriented prevention and socio-cultural aspects of gender discrimination in care.
Related news items
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more